IRIS
MINUTO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 18.656
AS - Asia 32
SA - Sud America 8
AF - Africa 1
Totale 18.697
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.656
CN - Cina 21
VN - Vietnam 8
EC - Ecuador 4
BR - Brasile 3
ID - Indonesia 2
AR - Argentina 1
SG - Singapore 1
ZA - Sudafrica 1
Totale 18.697
Salva come PNG Salva come JPEG
Città #
Genova 12.220
Genoa 3.732
Rapallo 1.625
Vado Ligure 1.056
Bordighera 20
Beijing 12
Rome 3
Guayaquil 2
Hanoi 2
Ho Chi Minh City 2
Surabaya 2
Campinas 1
Cape Town 1
Chacabuco 1
Da Nang 1
Huế 1
Hải Dương 1
Jaboatão dos Guararapes 1
Ninh Bình 1
Pinhais 1
Singapore 1
Totale 18.686
Salva come PNG Salva come JPEG
Nome #
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 203
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 199
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 195
Effect of environment on growth: auxological and hormonal parameters in African and Italian children 189
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 187
Pituitary image: pituicytoma. 183
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 174
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 171
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 170
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 170
Acromegaly is associated with increased cancer risk: A survey in Italy 170
Computed tomography colonography in acromegaly 169
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 168
The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology 168
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 164
Effects of the neuropeptide Y on estradiol and progesterone secretion by human granulosa cells in culture 163
Diagnostic value of the acid-labile subunit in Acromegaly: Evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3 162
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 162
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 162
Characterization of the IGF system in 15 patients with Alstrom syndrome. 162
The pathology of the ulnar nerve in acromegaly. 162
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 160
Assessment of the awareness and management of cardiovascular complications of acromegaly in Italy. The COM.E.T.A. (COMorbidities Evaluation and Treatment in Acromegaly) Study 158
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 156
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 156
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 155
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 152
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 152
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 152
Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient 150
Indirect evidence of hormone abuse. Proof of doping? 150
Pancreatic Islet Cell Tumor Secreting Insulin-Like Growth Factor Type-II in a Dog. 149
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 148
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 148
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? 147
Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. 147
Insulin-like growth factors (IGF-I and IGF-II) and IGF-binding protein-3 production by fibroblasts of patients with turner's syndrome in culture 146
Effect of the somatostatin analog, octreotide, and of other hormones on the release of the acid-labile subunit of the 150 kDa complex by rat hepatocyte in primary culture. 146
Effect of the acid-labile subunit on the binding of insulin-like growth factor (IGF)-binding protein-3 to [125I]IGF-I. J.Clin.Endocrinol.Metab. 80 (4):1318-1324, 1995. 144
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas 144
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 142
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 142
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 142
Initial staging of lymphoma with octreotide and other receptor imaging agents. 141
Paraneoplastic hypoglycemia due to an insulin-like growth factor type-II secreting hepatocellular carcinoma in a dog. 140
Growth hormone secretion in pubertal and adult subjects. 140
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 138
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 138
Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women 138
Somatostatin receptor scintigraphy in thoracic diseases 137
Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities 137
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 137
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 136
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 136
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 135
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 135
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 135
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 134
Rationale and design of PATRO Adults, a multicentre, noninterventional study of the long-term efficacy and safety of Omnitrope(R) for the treatment of adult patients with growth hormone deficiency 134
Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly 134
Evidence for autocrine mitogenic stimulation by somatomedin- C/insulin-like growth factor I on an established human lung cancer cell line 133
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 133
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 133
Sympathovagal imbalance in acromegalic patients 130
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 128
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 128
P68 Insulin-like growth factor (IGF) binding protein-3 inhibits IGF-II-stimulated IRS-1/PI-3-kinase activity and cell growth in human non-small cell lung cancer (NSCLC) cell lines 128
Polycythemia as rare secondary direct manifestation of acromegaly: management and single-centre epidemiological data. 127
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 126
Behaviour of typeII receptors of IGFs in different age and thyroid status in adult rat liver 126
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors 126
Decreased serum somatomedin C concentrations during sleep: temporal relationship to the nocturnal surges of growth hormone and prolactin. 125
Papillary thyroid cancer in a struma ovarii: a report of a rare case 125
Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. 124
Trigger Finger, an Early Musculoskeletal Manifestation of Acromegaly 124
P87 Effect of exenatide, sitagliptin and vildagliptin on IGF-I in diabetic patients 123
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 122
Partial characterization of somatomedin C-like immunoreactivity secreted by breast cancer cells in vitro. 122
Interrelationships between follicle stimulating hormone and the growth hormone--insulin-like growth factor--IGF-binding proteins axes in human granulosa cells in culture 122
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 121
Sympathovagal imbalance in transsexual subjects. 120
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 120
Replacement therapy and cardiovascular diseases 120
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: The case for 119
OR2,6 Interrelationship between somatostatin/dopamine pathways and growth factors in non-small lung cancer cells 119
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 118
Regulation Of Prostate Cancer Cell Proliferation By Somatostatin Receptor Activation 118
Cost-of-illness study in acromegalic patients in Italy 116
Effect of octreotide on circulating IGF-I chromatographic profile: evidence for an inhibitory action on the formation of the 150-kDa ternary complex 116
Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: implications for the in vivo visualization during somatostatin receptor scintigraphy. 115
Significant tumour shrinkage after 12 months of Lanreotide Autogel-120 mg treatment given first-line in acromegaly 114
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. 114
Effects of alpha-interferon on insulin-like growth factor-I, insulin-like growth factor-II and insulin-like growth factor binding protein-3 secretion by a human lung cancer cell line in vitro. 114
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children 114
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5 114
Wireless connections in a hospital ward: the WARD-IN-HAND Project 113
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 113
Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy 112
The undescended testis. Prevalence and clinical features 112
Novel chimeric somatostatin analogs: facts and perspectives 112
Totale 14.103
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.369
article - articoli 51.923
book - libri 0
conference - conferenze 2.384
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.062
Totale 110.738
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021779 0 0 0 79 82 74 62 108 93 116 77 88
2021/20221.863 35 97 168 233 72 128 134 434 89 174 58 241
2022/20231.937 177 143 37 227 310 351 3 130 303 5 226 25
2023/2024782 41 105 12 114 65 128 51 46 46 14 57 103
2024/20252.650 53 183 76 172 389 247 281 435 103 86 277 348
2025/20261.112 535 95 214 268 0 0 0 0 0 0 0 0
Totale 18.746